What is the MELISA Blood Test?
MELISA (Memory Lymphocyte ImmunoStimulation Assay) is a specialized lymphocyte transformation test marketed for detecting metal hypersensitivity, but the evidence shows it is neither sensitive nor specific for diagnosing metal allergy or associated chronic diseases, and it is not recommended for clinical use.
Test Description
MELISA is an in vitro blood test that measures lymphocyte proliferation in response to various metals (including aluminum, nickel, mercury, gold, palladium, titanium, and others). The test works by:
- Exposing a patient's lymphocytes to different metal concentrations
- Measuring cellular proliferation as an indicator of immune sensitization
- Calculating a "Stimulation Index" to determine reactivity 1, 2
The test was originally developed to screen for allergenic epitopes of drugs and chemicals, then adapted for metal sensitivity testing 3.
Critical Evidence Against Clinical Use
Lack of Sensitivity and Specificity
The most recent and rigorous study (2017) demonstrated that MELISA is neither sensitive nor specific for detecting metal hypersensitivity. In 16 patients with suspected autoimmune/inflammatory syndrome, only 9 showed any metal reactivity, with 7 patients testing completely negative despite clinical suspicion 4. This represents a 44% false-negative rate in a symptomatic population.
High False-Positive Rate
A 2005 Dutch medical journal review concluded that MELISA produces a high number of false-positive results, rendering it useless for diagnosing metal allergy 5. The claims that metal allergy plays a role in immune-mediated diseases, metabolic disorders, and neurological conditions lack sound scientific evidence 5.
Reproducibility Issues
While proponents claim 94% reproducibility 1, 2, this varies significantly based on:
- Lymphocyte concentration (higher concentrations produce stronger reactions regardless of true sensitivity)
- Mercury concentrations >0.5 μg/ml cause non-specific mitogenic reactions
- Absolute Stimulation Index values vary between tests, though qualitative results may be more consistent 2
Why This Test Is Not Recommended
Standard patch testing remains the gold standard for diagnosing metal allergy, particularly for contact dermatitis and delayed hypersensitivity reactions 6. Unlike MELISA:
- Patch testing has established sensitivity and specificity
- Results correlate with clinical outcomes
- It is included in evidence-based allergy guidelines 6
Common Pitfalls to Avoid
- Do not order MELISA for suspected metal allergy - Use validated patch testing instead
- Do not use MELISA results to guide dental restoration removal - Clinical correlation with patch testing is more appropriate
- Do not attribute chronic fatigue, autoimmune diseases, or neurological symptoms to metal sensitivity based on MELISA results - These associations lack scientific validation 5
When Metal Allergy Testing Is Appropriate
For patients with suspected metal hypersensitivity (contact dermatitis, oral symptoms with dental work, implant reactions):
- First-line: Patch testing with standardized metal allergens 6
- Consider testing for nickel, cobalt, chromium, gold, palladium based on exposure history
- Delayed readings at 48-96 hours are essential 6
- Clinical correlation is mandatory - positive tests without clinical symptoms do not require intervention
MELISA has no established role in clinical practice and should not be used for diagnostic or treatment decisions.